TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Snoring severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: signal intensity of liver
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response Rate in Patients with Stage IIIB/IV NSCLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of Rosiglitazone Maleate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cmax of Rosiglitazone Maleate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC0-infinity of Rosiglitazone Maleate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC0-t of Metformin Hydrochloride
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AUC0-infinity of Metformin Hydrochloride
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Subjects With Clinical Outcome of Cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Number of Drinks Per Day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Number of Drinks Consumed in Bar Lab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: structural change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of Yersinia spp. infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of Patients Alive
Endpoint domain: Mortality/survival
Primary endpoint: Hypertrophic Scarring (HTS) as Assessed by Score on the Manchester Scar Scale (MSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hypertrophic Scarring (HTS) as Assessed by Score on the Modified Scar Rating Scale (MSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Pain intensity and quality of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Health and Wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Occurrence of solicited local & general symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Frequencies of IgG PS-specific plasma cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of participants with self-reported outcome data at 12 weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of missing data in self-report outcome questionnaires
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Appropriateness of self-report outcome questionnaires (ceiling and floor effects)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Allodynic and hypoesthetic territories mapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cesarean Scar Defect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Patient Health Questionnaires-9 During Intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prostate-specific Antigen (PSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline 1-repetition maximum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forceplate AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in levels of 6-Hydroxymelatonin sulphate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep quality index score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Mean Change in Central Retinal Subfield Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Best Corrected Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of Dialysis Initiation, Kidney Transplantation, and Serum Creatinine Doubling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Feasibility of delivery higher than prescription doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Confirmed consistent use of an effective contraceptive method at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Pregnancy desire/aspirations among the HIV positive women
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma vitamin and mineral levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in weight-related outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Y-Balance Test Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binary Risk outcome of risk vs low risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of neonates achieving target vancomycin concentrations in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Major CIED Infection
Endpoint domain: Adverse events/effects
Primary endpoint: CIED Mechanical Complication
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Satiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Glucose Uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Newly Diagnosed HIV Infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Adherence to the trial protocol
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of recruiting and enrolling patients
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lumbar Spine Bone Mineral Density Percent Change From Baseline at Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Response rates to lucitanib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in OCT parameters over time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rest Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in Platelet Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Falls from wheelchairs
Endpoint domain: Adverse events/effects
Primary endpoint: High End State Function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in perioperative cognitive trajectories
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Radlex Scale for Diagnostic Quality Ratings - DE Predicate PA Chest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radlex Scale for Diagnostic Quality Ratings - DE Investigational Composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radlex Scale for Diagnostic Quality Ratings - DE Investigational High Energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radlex Scale for Diagnostic Quality Ratings - DE Investigational Low Energy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radlex Scale for Diagnostic Quality Ratings - DT Reference 1- PA Chest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of detection of invasive cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of PCOS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Prevalence of Diabetes Mellitus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Objective Cognition - Computerized Cognitive Tasks
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Subjective Cognitive Self-Efficacy - Cognitive Failures Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Anxiety - State-Trait Anxiety Inventory
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Precarious social conditions
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Relative change in serum potassium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resolution of RCDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin health parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: feasibility of cervical sympathetic block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quantitative assessments of dPET characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to achieve successful double lumen tube intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intramuscular Injection Achievement Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intramuscular Injection Application Skill Assessment Form
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scale of Student Satisfaction and Self-confidence in Learning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of specimens with grade I specimen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microbiological success
Endpoint domain: Adverse events/effects
Primary endpoint: Major CIED Infection Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Pulse Amplitude Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NK Cell activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Radiographic measurement of root length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dentinal wall thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quadriceps Muscle Strength Testing Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health-related Quality of Life Assessments Change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intraindividual reproducibility of skin fluorescence measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Comparison of B lymphocyte subtype B1b in LBW vs NBW infants
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: twenty-four hour newborn mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: intrapartum stillbirth rate
Endpoint domain: Mortality/survival
Primary endpoint: Increase and Maintain Hemoglobin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Granulocyte Colony Stimulating Factor (G-CSF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of radiopaque markers transferred to the large intestine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in Partial-onset Seizure Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Walking Ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Prevention and treatment of recurrent urinary tract infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cumulated incidence of response to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI Neuroimaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantitative Sensory Testing (QST), Vibratory Detection Thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper Limb Isometric Strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Decision outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient specific outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Carotenoid levels in the eye
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carotenoid levels in the skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average Systolic Blood Pressure (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: number of patients with treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: number of patients with abnormal laboratory values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of patients with abnormal instrumental tests (ECG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Adverse Events Related to Study Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Change in attachment status
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Objective Response Rate Per Prostate Cancer Clinical Trials Working Group 3 (ORR-PCWG3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prostate-Specific Antigen Response Rate (RR-PSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in Neurosensory Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Survival Probability at 2 Years
Endpoint domain: Mortality/survival
Primary endpoint: Size of Wheal Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change From Baseline in the Mean HAM-A Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of dysfunctions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance with the appropriate use of sterile medical devices
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Lactobacillus Plantarum Bacteremia Infections
Endpoint domain: Adverse events/effects
Primary endpoint: Injury area analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acute insulin release (AIRg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of patients progressing to severe COVID-19 or hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: World Health Organization Disability Assessment Scale II (WHO-DAS 2.0) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Veterans Rand 12-Item Health Survey (VR-12): Physical Component Score (PCS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Veterans Rand 12-Item Health Survey (VR-12): Mental Component Score (MCS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Growth slowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental Demand
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in frailty assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Subjective Score of Lenses
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Assessment of grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in total volume of weekly active energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Biopsy-confirmed Acute Rejection and/or Progression of Chronic Allograft Nephropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: percentage of prescribed diet consumed
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: intake of any extra food
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Quantification of FMD-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Re-Transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: FEV1 (Forced Respiratory Volume in 1 second)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Immunogenicity of herpes simplex vaccine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reactogenicity and safety of the vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Absolute change in daytime SBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants Who Met at Least One New Cerebral and Cardiovascular Events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes From Baseline in Metabolic Syndrome Parameters (Body Weight)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes From Baseline in Metabolic Syndrome Parameters (Haemoglobin A1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of dengue incidence
Endpoint domain: Mortality/survival
Primary endpoint: stability of fracture segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pressure threshold in hypogastrium that induces pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dermoscopic score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Presence or absence of a hip effusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cervical pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in Delayed Recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Ataxia assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Laboratory assessments (e.g. hematology)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Pediatric Pain Interference Scale (PPIS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in DAS-II General Conceptual Ability Standard Score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of progression to severe Alzheimer's disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: reducing pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improving quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mechanical ventilatory free days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: LH range in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: FSH range in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: AMH range in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: estradiol range in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: testosterone range in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: inhibin B range in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: No Primary Safety Events
Endpoint domain: Adverse events/effects
Primary endpoint: Muscle protein synthesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle protein breakdown
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: DAS28 (CRP) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression of Improvement (CGI-I) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Duration of in vivo persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antitumor effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of silent strokes detected by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Number of Pain Free Participants (Pain Freedom)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrapulmonary Lung deposition expressed as % of nominal dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes